{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:59:49Z","timestamp":1793876389206,"version":"4.7.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010891","name":"Portola Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ncl.2021.02.002","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T22:48:33Z","timestamp":1617230913000},"page":"405-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Intracerebral Hemorrhage"],"prefix":"10.1016","volume":"39","author":[{"given":"Carlos S.","family":"Kase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2021.02.002_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","article-title":"Incidence, case fatality, and functional outcome of intracerebral hemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis","volume":"9","author":"van Asch CJJ","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib2","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ana.410290614","article-title":"Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival","volume":"29","author":"Thurim","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinte.164.8.880","article-title":"The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage","volume":"164","author":"Rosand","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ncl.2021.02.002_bib4","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.STR.27.10.1783","article-title":"Enlargement of spontaneous intracerebral hemorrhage: incidence and time course","volume":"27","author":"Kazui","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.STR.28.1.1","article-title":"Early hemorrhage growth in patients with intracerebral hemorrhage","volume":"28","author":"Brott","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib6","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1161\/01.STR.0000259633.59404.f3","article-title":"CT angiography \u201cspot sign\u201d predicts hematoma expansion in acute intracerebral hemorrhage","volume":"38","author":"Wada","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1212\/01.wnl.0000257087.22852.21","article-title":"Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage","volume":"68","author":"Goldstein","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2021.02.002_bib8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1474-4422(12)70038-8","article-title":"Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study","volume":"11","author":"Demchuk","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1474-4422(18)30253-9","article-title":"Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data","volume":"17","author":"Al-Shahi Salman","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib10","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","article-title":"Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage","volume":"368","author":"Anderson","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2021.02.002_bib11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","article-title":"Intensive blood-pressure lowering in patients with acute cerebral hemorrhage","volume":"375","author":"Qureshi","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2021.02.002_bib12","doi-asserted-by":"crossref","first-page":"e1058","DOI":"10.1212\/WNL.0000000000006156","article-title":"Cerebral ischemia and deterioration with lower blood pressure target in intracerebral hemorrhage","volume":"91","author":"Buletko","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2021.02.002_bib13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/01.WNL.0000138428.40673.83","article-title":"Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage","volume":"63","author":"Flibotte","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2021.02.002_bib14","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/STROKEAHA.108.520668","article-title":"Hematoma growth in oral anticoagulant related intracerebral hemorrhage","volume":"39","author":"Cucchiara","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.hest.2020.01.001","article-title":"Anticoagulant-associated intracerebral hemorrhage","volume":"1","author":"Morotti","year":"2020","journal-title":"Brain Hemorrhages"},{"key":"10.1016\/j.ncl.2021.02.002_bib16","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1212\/WNL.0000000000003886","article-title":"Intracerebral hemorrhage associated with different oral anticoagulants","volume":"88","author":"Wilson","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2021.02.002_bib17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","article-title":"Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomized trial","volume":"15","author":"Steiner","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib18","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s40265-019-01179-w","article-title":"Prothrombin complex concentrates are superior to fresh frozen plasma for emergency reversal of vitamin K antagonists: a meta-analysis in 2606 subjects","volume":"79","author":"Hill","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ncl.2021.02.002_bib19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ncl.2021.02.002_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamaneurol.2015.3682","article-title":"Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants","volume":"73","author":"Purrucker","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ana.25134","article-title":"Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage","volume":"83","author":"Gerner","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib22","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/STROKEAHA.116.013343","article-title":"Anticoagulant-associated intracranial hemorrhage in the era of reversal agents","volume":"48","author":"Steiner","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jth.13227","article-title":"for the Subcommittee on Control of Anticoagulation. When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH","volume":"14","author":"Levy","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ncl.2021.02.002_bib24","doi-asserted-by":"crossref","first-page":"e000274","DOI":"10.1136\/svn-2019-000274","article-title":"Coagulopathy reversal in intracerebral hemorrhage","volume":"5","author":"Sweidan","year":"2020","journal-title":"Stroke & Vascular Neurology"},{"key":"10.1016\/j.ncl.2021.02.002_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000339675","article-title":"Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions","volume":"34","author":"Seet","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ncl.2021.02.002_bib26","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1161\/STR.0000000000000152","article-title":"Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"48","author":"Yaghi","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.STR.0000196991.03618.31","article-title":"Regular aspirin use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death","volume":"37","author":"Saloheimo","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib28","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/01.wnl.0000342709.31341.88","article-title":"Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH","volume":"72","author":"Sansing","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2021.02.002_bib29","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2021.02.002_bib30","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/CON.0000000000000672","article-title":"Intracerebral hemorrhage","volume":"24","author":"Ziai","year":"2018","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.ncl.2021.02.002_bib31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2141.1997.4463256.x","article-title":"Platelet activity of high-dose factor VIIa is independent of tissue factor","volume":"99","author":"Monroe","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ncl.2021.02.002_bib32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage","volume":"352","author":"Mayer","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2021.02.002_bib33","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ncl.2021.02.002_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/STROKEAHA.109.565382","article-title":"The spot sign score in primary intracerebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors","volume":"41","author":"Delgado Almandoz","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib35","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jamaneurol.2019.2636","article-title":"Effect of recombinant activated coagulation factor VII on hemorrhage expansion among patients with spot sign-positive acute intracerebral hemorrhage: the SPOTLIGHT and STOP-IT randomized clinical trials","volume":"76","author":"Gladstone","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib36","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(11)60278-X","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial","volume":"377","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2021.02.002_bib37","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2021.02.002_bib38","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(18)31033-X","article-title":"Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomized, placebo-controlled, phase 3 superiority trial","volume":"391","author":"Sprigg","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2021.02.002_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(17)32455-8","article-title":"Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients","volume":"391","author":"Gayet-Ageron","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2021.02.002_bib40","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(18)31878-6","article-title":"Intracerebral haemorrhage: current approaches to acute management","volume":"392","author":"Cordonnier","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2021.02.002_bib41","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0140-6736(09)60371-8","article-title":"Intracerebral haemorrhage","volume":"373","author":"Qureshi","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2021.02.002_bib42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/01.WCB.0000073905.87928.6D","article-title":"Heme and iron metabolism: role in cerebral hemorrhage","volume":"23","author":"Wagner","year":"2003","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1016\/j.ncl.2021.02.002_bib43","first-page":"672","article-title":"Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage","volume":"100","author":"Nakamura","year":"2004","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.ncl.2021.02.002_bib44","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1161\/STROKEAHA.111.617589","article-title":"Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage","volume":"42","author":"Selim","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib45","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S1474-4422(19)30069-9","article-title":"Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial","volume":"18","author":"Selim","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib46","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12028-017-0425-4","article-title":"Functional improvement among intracerebral hemorrhage survivors up to 12\u00a0months post-injury","volume":"27","author":"Sreekrishnan","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ncl.2021.02.002_bib47","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jamaneurol.2014.1065","article-title":"Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study","volume":"71","author":"Fu","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib48","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/WNL.56.10.1294","article-title":"Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage","volume":"56","author":"Morgenstern","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2021.02.002_bib49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(05)70233-6","article-title":"Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial","volume":"365","author":"Mendelow","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2021.02.002_bib50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(13)60986-1","article-title":"Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial","volume":"382","author":"Mendelow","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2021.02.002_bib51","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/STROKEAHA.112.667535","article-title":"Minimally invasive surgery for spontaneous supratentorial intracerebral hemorrhage: a meta-analysis of randomized controlled trials","volume":"43","author":"Zhou","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib52","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/STROKEAHA.118.020688","article-title":"Minimally invasive surgery for intracerebral hemorrhage","volume":"49","author":"Scaggiante","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib53","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12028-008-9074-y","article-title":"Stereotactic aspiration-thrombolysis of intracerebral hemorrhage and its impact on perihematoma brain edema","volume":"8","author":"Carhuapoma","year":"2008","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.ncl.2021.02.002_bib54","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S1474-4422(16)30234-4","article-title":"Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial","volume":"15","author":"Hanley","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib55","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(19)30195-3","article-title":"Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial","volume":"393","author":"Hanley","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2021.02.002_bib56","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/neuros\/nyz077","article-title":"MISTIE III Trial Investigators. Surgical performance determines functional outcome benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) procedure","volume":"84","author":"Awad","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ncl.2021.02.002_bib57","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1161\/STROKEAHA.116.013837","article-title":"ICES (intraoperative stereotactic computed tomography-guided endoscopic surgery) for brain hemorrhage","volume":"47","author":"Vespa","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib58","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/STR.0000000000000069","article-title":"Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"46","author":"Hemphill","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib59","doi-asserted-by":"crossref","first-page":"105540","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105540","article-title":"Impact of intracranial pressure monitor-guided therapy on neurologic outcome after spontaneous nontraumatic intracranial hemorrhage","volume":"30","author":"Menacho","year":"2020","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.ncl.2021.02.002_bib60","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/ijs.12309","article-title":"European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage","volume":"9","author":"Steiner","year":"2014","journal-title":"Int J Stroke"},{"key":"10.1016\/j.ncl.2021.02.002_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.25732","article-title":"Surgical intervention for supratentorial intracerebral hemorrhage","volume":"88","author":"Sondag","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2021.02.002_bib62","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/ana.25823","article-title":"Role of temporal sequence in treating intracerebral hemorrhage","volume":"88 with","author":"Hanley","year":"2020","journal-title":"Ann Neurol"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:18:05Z","timestamp":1760005085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861921000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0733861921000141"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2021.02.002","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracerebral Hemorrhage","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2021.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}